Rôle du Montelukast dans le traitement de l'asthme - Société ...
Rôle du Montelukast dans le traitement de l'asthme - Société ...
Rôle du Montelukast dans le traitement de l'asthme - Société ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
J.M. Lopes dos Santos / Revue française d’al<strong>le</strong>rgologie et d’immunologie clinique 45 (2005) 538–541541[3] McKean M, Ducharme F. Inha<strong>le</strong>d steroids for episodic viral wheeze ofchildhood (Cochrane review). The Cochrane Library, Issue 4. Oxford:Update Software Ltd; 2002.[4] Knorr B, Matz J. Bernstein Ja et al. <strong>Montelukast</strong> for chronic asthma in6 to 14-year-old children; a randomized doub<strong>le</strong> blind trial. JAMA1998;279:1181–6.[5] Leff JA, Busse WW, Pearlman D, et al. <strong>Montelukast</strong>, a <strong>le</strong>ukotrienereceptorantagonist,for the treatment of mild asthma and exercisein<strong>du</strong>cedbronchoconstriction. N Engl J Med 1998;339:147–52.[6] Kemp JP, Dockhorn RJ, Shapiro GG, et al. <strong>Montelukast</strong> once dailyinhibits exercise-in<strong>du</strong>ced bronchoconstriction in 6 to14 year old childrenwith asthma. J Pediatr 1998;133:424–8.[7] Bisgaard H, Loland L, Anhoi J. NO in exha<strong>le</strong>d air of asthmaticchildren is re<strong>du</strong>ced by the <strong>le</strong>ukotriene antagonist montelukast. Am JRespir Crit Care Med 1999;160:1227–31.[8] Knorr B, Franchi LM, Bisgaard H, et al. a <strong>le</strong>ukotriene receptorantagonist for the treatment of persistent asthma in children aged 2 to5 years. Pediatrics 2001;:108–E48.[9] Volovitz B, Welliver RC, De Castro G, et al. The re<strong>le</strong>ase of <strong>le</strong>ukotrienesin the respiratory tract <strong>du</strong>ring infection with respiratory syncytialvirus: ro<strong>le</strong> in obstructive airway disease. Pediatr Res 1988;24:504–7.[10] Bisgaard H. A randomized trial of <strong>Montelukast</strong> in respiratory syncytialvirus postbronchiolitis. Am J Respir Crit Care Med 2003;167:379–83.[11] Bisgaard H, Zie<strong>le</strong>n S, Garcia-Garcia ML, et al. <strong>Montelukast</strong> re<strong>du</strong>cesrescue medication use in viral-in<strong>du</strong>ced asthma exacerbations (thePREVIA study). Am J Respir Crit Care Med 2004;169:A149.[12] Bisgaard H, Zie<strong>le</strong>n S, Garcia-Garcia ML, et al. <strong>Montelukast</strong> re<strong>du</strong>cesasthma exacerbation in 2-5 year old children with intermittent asthma.Am J Respir Crit Care Med 2005;171:315–22.